Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

PaperCitations, authors & open-access status

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 137 citations, 2016 year and bronze oa status.

137
Citations
2016
Year
bronze
OA Status

Related on ScholarIQ

Carol E. Semrad
Author
Gastroenterology
Journal
Celiac Disease Research and Management
Topic
Celiac Disease Research and Management
Topic
Food composition and properties
Topic
Microscopic Colitis
Topic
470M+ articles · free account